Thursday, March 20th, 2025 |
||
Room1 | Room 2 |
|
13:00 – 14:00 | ILD/IPF | Adherence |
14:00 – 15:00 | Allergy | Database & Coding |
15:00 – 16:00 | Technologies | Child Health |
16:00 – 16:30 | Coffee Break | |
16:30 – 17:30 | Cost Effectiveness | COPD |
17:30 – 18:30 | Environment, Epidemiology & Airways | Biomarkers & Severe Asthma |
Friday , March 21st, 2025 |
||
08:50 – 09:00 | Welcome Joan Β. Soriano, REG President |
|
09:00 – 10:00 | Inhaler Session - Propellants, planet, and the patient - the real-life impact Chairs: Omar Usmani & Mark Levy What does it mean to the Regulator? Maureen Donahue Hardwick What does it mean to the Industry? John Bell What does it mean to the Clinician? Toby Capstick |
|
10:00 – 10:30 | ILD/IPF Session Chair: Pilar Rivera Ortega Time taken from primary care referral to a specialist centre diagnosis of idiopathic pulmonary fibrosis: An opportunity to improve patient outcomes? Mark Jones |
|
10:30 – 10:45 | Coffee Break | |
10:45 – 11:30 | Readers', authors',
and editors' perspectives on observational research Chairs: Nicolas Roche & Therese Lapperre How to lie with statistics to a chest physician Joan Β. Soriano An Editor’s perspective on observational research David Price |
|
11:30 – 12:30 | Early
Career Travel Grant Winners Oral Presentation Chair: Dermot Ryan |
|
12:30 – 13:30 | Lunch Break & Poster viewing | |
13:30 – 15:00 | COPD Session Chairs: Bernardino Alcazar Navarrete & Frits M.E. Franssen Predicting the risk for first COPD severe exacerbation Bernardino Alcazar Navarrete Triple therapy and very severe COPD: Rational for a REG study Chin Kook Rhee New Drugs in COPD: Will they make a real-life difference? Nicolas Roche |
|
15:00 – 15:30 | Coffee Break | |
15:30 – 16:25 |
United Airways Disease session |
|
16:25 – 17:10 | AI/Digital in Respiratory Diseases session Chairs: Job van Boven & Fulvio Braido Can interactions with AIs provide patient support? Alan Kaplan Can digital adherence support prevent disease progression? Amy Chan |
|
17:10 – 17:55 | PRO/CON – Vaccines Chair: Joan Β. Soriano Pneumococcal vaccine is the most important respiratory vaccine for our high-risk patients to receive PRO: Filipe Froes RSV is the most important respiratory vaccine for our high-risk patients to receive CON: Alan Kaplan Vote & Summary Discussion Joan Β. Soriano |
|
Saturday, March 22nd, 2025 |
||
09:00 – 10:00 | Asthma Session - Expansion
of biologic use in asthma: Where to? Chairs: Nikos Papadopoulos & Jennifer Quint Younger age Adnan Custovic Milder disease Enrico Marco Heffler Multimorbidities Désirée Larenas-Linnemann |
|
10:00 – 10:45 |
Bronchiectasis Session Chair: Nicolas Roche Current and future perspectives in the treatment of bronchiectasis Eva Van Braeckel |
|
10:45 – 11:00 | Coffee Break | |
11:00 – 12:35 | Improving severe asthma care - ISAR’s research and quality improvement highlights Chairs: David Price & Veronica Mendez Exploring definitions and predictors of severe asthma remission post-biologic (FULL BEAM II) Luis Perez-de-Llano & Ghislaine Scelo What comes next for research on severe asthma remission? (GLEAM and SPOTLIGHT) Walter G. Canonica & Victoria Carter Practice change in severe asthma - where are we now in terms of standardizing care and data management Désirée Larenas-Linnemann & Celine Goh Impact of biologics on new onset of OCS-related outcomes in severe asthma (SOLAR II) David Price & Piotr Kuna Eliminating long-term OCS and frequent intermittent OCS Pujan Patel & Freya Tyrer Modelling the health system impact of earlier intervention in severe asthma Soram Patel & Alison Evans |
|
12:35 – 13:50 | Integrating
RWE into Guidelines session Chairs: Walter G. Canonica & Maria Jose Torres The need for RWE to be included in guidelines Stefano Del Giacco The GRADE system to integrate RWE Holger Schunemann Real-Life experience of guideline creation Nicolas Roche Discussion |
|
13:50 | Meeting Close |